- ICH GCP
- Registre américain des essais cliniques
- Essai clinique NCT01492595
Screening of Children in Household Contact With Adult TB Patients in Mbarara Hospital, Uganda (TBcontact)
Screening of Children in Household Contact With Adult TB Patients in Mbarara Hospital, Uganda: An Open Cohort of Children <5 Years in Contact With Newly Diagnosed Adult TB Cases in Mbarara Hospital
Aperçu de l'étude
Statut
Les conditions
Description détaillée
Because children with tuberculosis (TB) are usually smear-negative and therefore less infectious, they are generally not considered a public health risk. Up to 70% of children living in the same household with an adult with infectious TB will become infected, and more than 20% of them will develop active TB disease, usually within 12 months. The individual risk of developing disease once infected is highest in children <5 years. In addition, children under 5 years are at higher risk of developing disseminated forms of TB. The impact of childhood TB is worsened by co-infection with HIV. Contact tracing, investigation and prophylaxis of childhood contacts of adult TB cases are widely recommended but rarely practiced in developing countries. The World Health Organization recommends that all NTPs screen household contacts for symptoms of disease and offer isoniazid preventive therapy (i.e. daily isoniazid for at least 6 months) to children aged less than 5 years and to all HIV-infected children who are household contacts. In Mbarara, an area with a high incidence of TB, no program currently exists for the routine investigation of child contacts of adult pulmonary TB cases. Almost all child TB cases registered are found through the evaluation of symptomatic children, often long after the adult source-cases have been investigated and treated. The number of adult cases with pulmonary TB, together with the population structure in Mbarara (>50% of the total population being children) suggests that the number of childhood TB cases is probably higher than current hospital records indicate.
The proposed study aims to establish a pilot program through a prospective cohort study offering routine contact tracing, investigation and prophylaxis for LTBI, and treatment of TB disease to children <5 years living in the same household as adults diagnosed with smear/culture-positive pulmonary TB in Mbarara Regional Referral Hospital. The study will also generate much needed data on the utility of simple symptom-based screening of child contacts for TB disease in areas where access to radiological examination and tuberculin skin test are limited and on the efficacy and safety of IPT, in a region with a significant problem of HIV co-infection.
Children aged 1 month to 5 years living in the same household (a house or cluster of houses on the same plot) with a newly diagnosed adult case of smear and/or culture-positive TB will be eligible for the study. Children will undergo a physical examination, chest Xray, tuberculin skin test and specimen collection in case of symptoms. Children will then be classified as active TB, TB infected and non infected cases. TB infected and non infected children will receive 6 months isoniazid prophylaxis with monthly monitoring of acceptability and tolerability. A final clinical assessment will be performed at 9 months. A total of 577 children contacts will be enrolled.
Type d'étude
Inscription (Réel)
Critères de participation
Critère d'éligibilité
Âges éligibles pour étudier
Accepte les volontaires sains
Sexes éligibles pour l'étude
Méthode d'échantillonnage
Population étudiée
La description
Inclusion Criteria:
- Any child who has lived in the same household with the index case continuously for at least 2 weeks within the 3-month period immediately preceding the diagnosis of smear- positive or culture-positive TB in the index case.
- Informed consent signed by the parent or legal guardian
- Living within a 2-hour radius of Mbarara town
Exclusion Criteria:
- Child currently receiving anti-tuberculosis treatment
- Child has received a full course of anti-TB treatment within the last 6 months
Plan d'étude
Comment l'étude est-elle conçue ?
Détails de conception
Que mesure l'étude ?
Principaux critères de jugement
Mesure des résultats |
Délai |
|---|---|
|
Proportion of <5 year-old child contacts classified as active TB disease, LTBI or no infection
Délai: Baseline
|
Baseline
|
Mesures de résultats secondaires
Mesure des résultats |
Délai |
|---|---|
|
Number of children <5 years exposed to TB in the household of adult index cases
Délai: Baseline
|
Baseline
|
|
Number of contacts identified as active TB basing on a symptom-based approach compared with those based on chest radiography
Délai: 9 months
|
9 months
|
|
Proportion of contacts with HIV co-infection classified as non infected, LTBI or active TB
Délai: 9 months
|
9 months
|
|
Median duration of exposure to symptomatic source case among the contacts in the various classes
Délai: Baseline
|
Baseline
|
|
Association of various risk factors with the final classification of contacts after assessment
Délai: 9 months
|
9 months
|
|
Proportion of children with LTBI successfully treated (prevented from developing active TB disease) among HIV-infected and uninfected children
Délai: 9 months
|
9 months
|
|
Proportion of children with no TB infection or disease successfully treated (prevented from developing active TB disease or LTBI)
Délai: 9 months
|
9 months
|
|
Proportion of adverse events on treatment of TB disease, LTBI and TB exposure
Délai: 9 months
|
9 months
|
|
Adherence to IPT regimens
Délai: 9 months
|
9 months
|
Collaborateurs et enquêteurs
Parrainer
Les enquêteurs
- Chercheur principal: Julius Kiwanuka, MD, Mbarara University of Science and Technology
Dates d'enregistrement des études
Dates principales de l'étude
Début de l'étude
Achèvement primaire (Réel)
Achèvement de l'étude (Réel)
Dates d'inscription aux études
Première soumission
Première soumission répondant aux critères de contrôle qualité
Première publication (Estimation)
Mises à jour des dossiers d'étude
Dernière mise à jour publiée (Estimation)
Dernière mise à jour soumise répondant aux critères de contrôle qualité
Dernière vérification
Plus d'information
Termes liés à cette étude
Mots clés
Termes MeSH pertinents supplémentaires
Autres numéros d'identification d'étude
- Epicentre/MBA/2011/TBcontact
Plan pour les données individuelles des participants (IPD)
Prévoyez-vous de partager les données individuelles des participants (DPI) ?
Ces informations ont été extraites directement du site Web clinicaltrials.gov sans aucune modification. Si vous avez des demandes de modification, de suppression ou de mise à jour des détails de votre étude, veuillez contacter register@clinicaltrials.gov. Dès qu'un changement est mis en œuvre sur clinicaltrials.gov, il sera également mis à jour automatiquement sur notre site Web .